SHIONOGI, INC.
FLORHAM PARK, NJ

Shionogi Inc., headquartered in Florham Park, NJ, is a wholly-owned U.S. subsidiary of Shionogi & Co., Ltd., a historic global pharmaceutical company with over 139 years of experience based in Osaka, Japan. Established through the acquisition and merger of Sciele Pharma, Inc. and an existing development organization, Shionogi Inc. was formed in 2011 to leverage Shionogi's science-driven legacy for drug discovery and commercialization. The firm concentrates on addressing unmet medical needs across areas such as infectious diseases, pain management, chronic liver disease, inflammatory and neuropathic pain, Alzheimer’s Disease, and ADHD. Shionogi Inc.'s mission is committed to providing the best possible medicines, focusing on fostering health and well-being for patients. The company harnesses its deep-rooted expertise in anti-infective research, having contributed significantly to advancements in treatments against evolving bacterial and viral threats due to resistance issues. As part of its strategy, Shionogi collaborates with innovative partners worldwide to expedite the development process from laboratory research through clinical trials to market delivery. Key milestones include obtaining FDA approval for Symproic, marking the first medicine wholly researched by Shionogi that was developed and approved globally. Currently, Shionogi Inc. boasts a robust framework capable of managing multiple late-stage clinical programs and submitting new drug applications across diverse regions. The leadership at Shionogi Inc. brings extensive experience in pharmaceutical research and development, including Dr. Takayuki Yoshioka, who oversees supply chain strategies post his tenure as Senior Executive Officer for global supply and quality management. With over 29 years at the company, he has guided multiple capacities within Shionogi’s operations on a global scale. Mr. Hara serves as Executive Vice President and Chief Financial Officer, with a rich background from various corporate functions spanning finance, business development, and administration since joining Shionogi based in Japan in 1995. Additionally, Gary Dickinson spearheads the Human Resources function for Shionogi Inc., leveraging his expertise developed across major corporations to enhance the firm’s growth. Under the guidance of a formidable leadership team, Shionogi Inc. continues to expand its reach and impact within the pharmaceutical industry.